2024 Healthcare & Pharmaceuticalscategory US FDA declines full approval for Intercept's liver disease drug November 12, 2024 Healthcare & Pharmaceuticalscategory Novavax cuts 2024 revenue forecast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback